We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.58B
AUM Growth
+$66.2M
Cap. Flow
-$35.1M
Cap. Flow %
-2.23%
Top 10 Hldgs %
38.87%
Holding
195
New
31
Increased
63
Reduced
42
Closed
47

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$53.9M
2
STWD icon
Starwood Property Trust
STWD
+$42.6M
3
VSAT icon
Viasat
VSAT
+$34.9M
4
YELP icon
Yelp
YELP
+$31M
5
TMUS icon
T-Mobile US
TMUS
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Healthcare 19.96%
3 Financials 15.02%
4 Real Estate 13.01%
5 Communication Services 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$18.5M 1.18%
435,900
+132,200
+44% +$5.39M
CRSP icon
27
CRISPR Therapeutics
CRSP
$5.01B
$17.9M 1.14%
824,864
-13,927
-2% -$273K
WELL icon
28
Welltower
WELL
$168B
$17.5M 1.11%
255,600
+101,000
+65% +$6.81M
LADR
29
Ladder Capital
LADR
$1.21B
$15.5M 0.99%
1,076,178
+141,516
+15% +$1.99M
BIIB icon
30
Biogen
BIIB
$31.9B
$15.4M 0.98%
56,344
-6,635
-11% -$1.88M
LEN icon
31
Lennar Class A
LEN
$19.3B
$15.3M 0.97%
313,886
-414,341
-57% -$18.8M
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$130B
$15.3M 0.97%
175,148
+65,800
+60% +$5.79M
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
$15.1M 0.96%
124,700
+119,800
+2,445% +$15.4M
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.6M 0.93%
898,750
+549,100
+157% +$7.95M
LOGM
35
DELISTED
LogMein, Inc.
LOGM
$14.1M 0.9%
144,834
+123,400
+576% +$12.3M
CTSH icon
36
Cognizant
CTSH
$28.5B
$13.1M 0.83%
+219,300
New +$12.6M
BIDU icon
37
Baidu
BIDU
$30.8B
$12.9M 0.82%
74,530
+16,130
+28% +$2.84M
ELLI
38
DELISTED
Ellie Mae Inc
ELLI
$12.4M 0.79%
+124,000
New +$11.4M
PFE icon
39
Pfizer
PFE
$157B
$12.4M 0.79%
381,232
+70,934
+23% +$2.24M
CELG
40
DELISTED
Celgene Corp
CELG
$12.2M 0.77%
98,000
-37,676
-28% -$4.51M
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11.9M 0.75%
98,200
+50,900
+108% +$6.24M
W icon
42
Wayfair
W
$14.2B
$11.7M 0.74%
318,664
+100,482
+46% +$3.97M
AKRX
43
DELISTED
Akorn Inc
AKRX
$11.7M 0.74%
485,371
+201,400
+71% +$4.38M
VRTU
44
DELISTED
Virtusa Corporation
VRTU
$11.6M 0.74%
420,800
+201,500
+92% +$5.8M
MTGE
45
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$11.2M 0.71%
671,465
+183,561
+38% +$3M
TPH
46
DELISTED
Tri Pointe Homes
TPH
$11.1M 0.71%
916,442
+564,971
+161% +$6.94M
WVE icon
47
Wave Life Sciences
WVE
$879M
$10.9M 0.69%
408,006
+196,903
+93% +$5.5M
CRM icon
48
Salesforce
CRM
$210B
$10.7M 0.68%
129,500
+33,400
+35% +$2.67M
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.22T
$10.2M 0.65%
241,000
-83,480
-26% -$3.51M
PE
50
DELISTED
PARSLEY ENERGY INC
PE
$10.1M 0.64%
311,967
+150,800
+94% +$4.99M

Similar funds

Clough Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Clough Capital Partners held 195 positions worth $1.58B, up 4.4% from $1.51B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Clough Capital Partners's Q1 2017 filing shows 31 new, 63 increased, 42 reduced and 47 closed positions. Its largest new stake was Cognizant: 219,300 shares worth $13.1M. The largest sale was EOG Resources, an estimated $31M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Clough Capital Partners's largest Q1 2017 buy was Cognizant: 219,300 shares worth $13.1M.
  • Clough Capital Partners added most to Apple in Q1 2017, an estimated $53.9M increase.
  • Clough Capital Partners's biggest Q1 2017 reduction was Lennar Class A, cutting an estimated $18.8M.
  • Clough Capital Partners fully exited EOG Resources in Q1 2017, selling an estimated $31M.
  • Clough Capital Partners's ten largest holdings make up 39% of its $1.58B portfolio in Q1 2017.
  • Clough Capital Partners opened 31 new positions and closed 47 in Q1 2017.
  • Clough Capital Partners's portfolio value rose 4.4% quarter-over-quarter to $1.58B.

Based on Clough Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.